to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Design elements that build brand awareness for your business constitute its "trade dress" and can be protected by federal and state trademark laws. Learn how to enhance trade-dress protection and defend against infringement by competitors.
Learn what a license really covers, what details to spell out and how to provide for accurate record-keeping, so as to prevent trouble later on. This article reviews the basic provisions, from boilerplate to bones of contention.
If your personnel, products, partners and resources are mobilized for overseas expansion, you can overcome the bureaucratic, cultural and economic obstacles outlined in the previous article of this series. Read this one to learn the underlying conditions that foster success.
Taking your company global can supply resources, help the business grow and bring desirable technological development to other countries. To do it right, consider the obstacles and gather background information first.
Know the advantages and disadvantages of different arrangements for doing business overseas, and the major legal issues arising from each, before you go global. Then, make sure everyone involved complies with your standards for behavior and performance.
Patents protect inventors and may enrich companies--but the application and registration process may be long and costly. Here are the statutory requirements, plus the basics of an effective patent protection program.
When facing the prospect of litigation, entrepreneurs should be sure to explore all of the options beyond forging ahead to court. This tool is a series of checklists designed to help entrepreneurs conduct a litigation-focused cost-benefit analysis, such as deciding to explore settlement or alternative dispute resolution.
People infected with HIV, whether or not they have AIDS symptoms, are protected in the workplace by federal and state laws concerning discrimination and disability. These guidelines for education, testing and accommodation policies can help entrepreneurs avoid problems.
Peter A. Seligmann is one of today's most dynamic leaders in the global conservation movement, where he has brought innovation and action to the forefront of biodiversity protection for more than 25 years. In 1987, he co-founded Conservation International, and as Chairman and CEO he has positioned CI at the cutting edge of conservation, creating lasting solutions to biodiversity and sustainable development challenges. Seligmann holds a masters degree from Yale University's School of Forestry and Environmental Science and an honorary Doctorate in Science from Michigan State University. In 2001, he was awarded the Order of the Golden Ark from the Netherlands. Seligmann serves on the board of the Wild Salmon Center in Portland, Oregon, and the Mayor's Environmental Council in Washington, D.C. He also serves on several corporate boards, as well as on the advisory councils of the Jackson Hole Land Trust, Ecotrust and other not-for-profit organizations, including the Japanese Keidanren's Nature Conservation Fund. In 2000, President Clinton named him a member of the Enterprise for the Americas Board. Seligmann's work has been featured by ABC's "Nightline," CNN and Fortune Magazine. A strong advocate of building partnerships, Seligmann has forged groundbreaking joint projects between the environmental community and other sectors, including government and industry. In 1998, CI established the Center for Applied Biodiversity Science, and in 2001, the Center for Environmental Leadership in Business. In 2000, CI launched the Critical Ecosystem Partnership Fund in collaboration with the World Bank and the MacArthur Foundation. Under Seligmann's leadership, CI has pioneered conservation tools that are economically sound, scientifically based and culturally sensitive. He has guided CI to become a major international conservation leader, with field offices in more than 30 countries, and major influences
Beth joined Kleiner Perkins Caufield & Byers in May 2005 to work in life sciences. For the past 20 years, she has focused her career on introducing new innovative treatments for AIDS, arthritis, asthma, cancer, psoriasis, cardiovascular, metabolic, neurological and renal disorders. Seidenberg has introduced 10 innovative products to market and achieved over 40 regulatory approvals, including new indications and formulations, worldwide. These products have been successfully commercialized and provided benefits to millions of patients with grievous illnesses, and they have generated several billion dollars of revenue. Prior to joining KPCB, Beth was Senior Vice President, Global Development, and Chief Medical Officer at Amgen, Inc., the world's largest biotechnology company. During Beth's three years there, her responsibilities included all stages of clinical research, regulatory affairs, safety, health economics/reimbursement and medical affairs. During her tenure, five innovative products were approved for commercial use. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb Company and Merck & Co., Inc. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. Beth received her BS from Barnard College magna cum laude, Phi Beta Kappa; and her medical degree from the University Of Miami School Of Medicine, alpha omega alpha. Her post-graduate training was completed at Johns Hopkins, George Washington School of Medicine and the National Institutes of Health. She is a member of the Johns Hopkins Bloomberg School of Public Health Advisory Board and Barnard College Science Advisory Board.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.
